April 8, 2025 - 03:57

Troy Goldie has been appointed as the inaugural Chief Technology Officer (CTO) at GCI, marking a significant milestone for the company. Goldie, who previously held an executive position at Lumen Technologies, brings a wealth of experience and expertise to this newly-created role.
In his new position, Goldie will be responsible for overseeing GCI's technology strategy and implementation, aiming to enhance the company's competitive edge in the telecommunications sector. His appointment reflects GCI's commitment to innovation and improving customer experiences through advanced technology solutions.
Goldie's extensive background in the industry positions him well to lead GCI into a new era of technological advancement. His leadership will be crucial as the company navigates the rapidly evolving landscape of telecommunications and seeks to leverage new technologies to better serve its customers. The addition of a CTO underscores GCI's dedication to staying at the forefront of technology in a highly competitive market.
August 9, 2026 - 18:31
County agenda features tax, technology and fairgroundsThe meeting will center on how to fund the ongoing fairgrounds project, a long-discussed priority for the county. Officials are expected to review the latest cost estimates and possible revenue...
August 9, 2026 - 00:24
‘AI slop’ crackdown: LinkedIn, Snap target low-quality gen-AI contentSocial platforms are starting to push back against the flood of generic, machine-generated posts, but they are doing so carefully. LinkedIn and Snap have both announced new measures aimed at...
August 8, 2026 - 05:47
Why GigaCloud Technology (GCT) Is Up 21.7% After Strong Q2 Results And New Buyback PlanGigaCloud Technology saw its stock surge 21.7% in early trading following the release of its second-quarter financial results and the announcement of a new capital return program. The company...
August 7, 2026 - 22:40
As FDA Approves First-Ever mRNA Flu Vaccine For Older Adults, Past KFF Polling Showed Most In This Age Group Were Uncertain About the Technology’s SafetyOn August 5, 2026, the U.S. Food and Drug Administration gave the green light to the first messenger RNA flu vaccine for adults aged 50 and older. The decision came after a clinical trial involving...